hydroxide;hydrate | 31748-17-1

• 分子结构分类: 无机化合物 - 均质非金属化合物 - 非金属氧阴离子化合物
• 英文名称: hydroxide;hydrate
• CAS: 31748-17-1
• 化学式: HO*H₂O
• 分子量: 35.0226
• InChiKey: JEGUKCSWCFPDGT-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -1.0
• 重原子数：
  2
• 可旋转键数：
  0
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-[2-(3-Benzofuran-2-yl-4-bromobut-2-enoylamino)ethoxy]benzoic acid methyl ester 、 hydroxide;hydrate 、 N-(2-羟乙基)-吡咯烷 在 四丁基碘化铵 水 、 Brine 、 Sodium sulfate-III 、 methanol-dichloromethane 作用下， 以 N,N-二甲基甲酰胺 、 乙酸乙酯 为溶剂， 反应 16.0h， 以to give 4-{2-[3-benzofuran-2-yl-4-(2-pyrrolidin-1-yl-ethoxy)but-2-enoylamino]ethoxy}benzoic acid methyl ester (0.94 mg) as an oil的产率得到4-{2-[3-Benzofuran-2-yl-4-(2-pyrrolidin-1-yl-ethoxy)but-2-enoylamino]ethoxy}benzoic acid methyl ester
  参考文献：
  名称：

  Hydroxamates as therapeutic agents

  摘要：

  本发明涉及某些羟肟酸衍生物，它们是组蛋白去乙酰化酶的抑制剂，因此在治疗与组蛋白去乙酰化酶活性有关的疾病方面有用。还公开了制备这些化合物的制药组合物和方法。

  公开号：

  US07368476B2
• 作为产物：
  描述：

  、 氢气 以 gas 为溶剂， 生成 hydroxide;hydrate
  参考文献：
  名称：

  Effects of hydration on reactions of oxide hydrate [O-(H2O)n (n = 0-2)]. 2. Reactions with hydrogen and deuterium

  摘要：

  The rate constants for the reactions of O-(H2O)n (n = 0-2) with H2 and D2 have been measured as a function of temperature. In addition, the dependences of the rate constants on average center-of-mass kinetic energy () and the branching ratios for n = 0 have been measured at several temperatures. For n = 0, the reactions with H2 and D2 are 48% and 50% efficient, respectively, and depend only weakly on temperature and . Both associative detachment and a channel that produces OH- are observed. The minor ( < 15%) OH- channel becomes more important at higher temperatures and . One H2O ligand reduces the rate constants on the order of a factor of 50. The reaction pathways for n = 1 are approximately 90% associative detachment and 10% production of OH-(H2O). The rate constants for n = 1 are found to increase with increasing temperature. The second H2O ligand reduces the rates to below our detectable limit. No dependence on rotational energy was found in either the rate constant or the branching ratio for n = 0.

  DOI：

  10.1021/j100162a039

文献信息

• Novel hydroxamates as therapeutic agents
  申请人：Setti L. Eduardo

  公开号：US20050227976A1

  公开（公告）日：2005-10-13

  The present invention is directed to certain hydroxamate derivatives that are inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.

  本发明涉及某些羟肟酸衍生物，其是组蛋白去乙酰化酶的抑制剂，因此对于与组蛋白去乙酰化酶活性相关的疾病的治疗是有用的。本发明还揭示了制备这些化合物的药物组合物和方法。
• Effects of hydration on reactions of oxide hydrate [O-(H2O)n (n = 0-2)]. 2. Reactions with hydrogen and deuterium
  作者：Albert A. Viggiano、Robert A. Morris、Carol A. Deakyne、F. Dale、John F. Paulson

  DOI：10.1021/j100162a039

  日期：1991.5

  The rate constants for the reactions of O-(H2O)n (n = 0-2) with H2 and D2 have been measured as a function of temperature. In addition, the dependences of the rate constants on average center-of-mass kinetic energy () and the branching ratios for n = 0 have been measured at several temperatures. For n = 0, the reactions with H2 and D2 are 48% and 50% efficient, respectively, and depend only weakly on temperature and . Both associative detachment and a channel that produces OH- are observed. The minor ( < 15%) OH- channel becomes more important at higher temperatures and . One H2O ligand reduces the rate constants on the order of a factor of 50. The reaction pathways for n = 1 are approximately 90% associative detachment and 10% production of OH-(H2O). The rate constants for n = 1 are found to increase with increasing temperature. The second H2O ligand reduces the rates to below our detectable limit. No dependence on rotational energy was found in either the rate constant or the branching ratio for n = 0.
• Hydroxamates as therapeutic agents
  申请人：Pharmacyclics, Inc.

  公开号：US07368476B2

  公开（公告）日：2008-05-06

  The present invention is directed to certain hydroxamate derivatives that are inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.

  本发明涉及某些羟肟酸衍生物，它们是组蛋白去乙酰化酶的抑制剂，因此在治疗与组蛋白去乙酰化酶活性有关的疾病方面有用。还公开了制备这些化合物的制药组合物和方法。